Status:

TERMINATED

Teriparatide for Postsurgical Hypoparathyroidism

Lead Sponsor:

Mayo Clinic

Conditions:

Hypoparathyroidism Post-surgical

Eligibility:

All Genders

18-80 years

Phase:

PHASE2

Brief Summary

This study evaluated the effects of teriparatide (Forteo) on low calcium levels in the setting of thyroid surgery associated with low parathyroid hormone. The hypothesis was that teriparatide ( Forteo...

Detailed Description

Transient hypoparathyroidism with hypocalcemia occurs in up to 20 % of patients after surgery for thyroid cancer, multinodular goiter or Graves' disease and is severe in around 3 to 18% of cases. Seve...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Patients post bilateral thyroid bed surgery (cancer, Graves disease, multinodular goiter)
  • Symptomatic hypocalcemia
  • Total calcium \< 8 mg/dL persisting after 24 hours of therapy with calcitriol (minimum 0.25 mcg twice a day) and calcium supplementation (minimum 1.5 grams of elemental calcium per day)
  • Parathyroid hormone (PTH) level below low end of normal range
  • Exclusion criteria (all subjects):
  • Renal failure
  • Any prior parathyroid pathology
  • Pre-existing hypercalcemia
  • Metabolic bone diseases other than osteoporosis
  • Pagets disease
  • Exclusion criteria (active treatment subjects only):
  • Ongoing therapy with Forteo for osteoporosis
  • Active non-thyroidal malignancy or suspicion of residual thyroid malignancy
  • History of skeletal malignancies, primary or metastatic
  • Pregnancy
  • Active or recent urolithiasis
  • Digitalis therapy
  • Patients at increased baseline risk for osteosarcoma, i.e., family history of osteosarcoma or prior radiation therapy involving the skeleton
  • Pediatric populations
  • Unexplained elevations of alkaline phosphatase

Exclusion

    Key Trial Info

    Start Date :

    November 1 2010

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 1 2013

    Estimated Enrollment :

    5 Patients enrolled

    Trial Details

    Trial ID

    NCT01171690

    Start Date

    November 1 2010

    End Date

    December 1 2013

    Last Update

    December 22 2014

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Mayo Clinic

    Rochester, Minnesota, United States, 55905